E-LIB Suche - Ergebnisse für: Celen Mustafa

1

Five years follow-up of 96 weeks peginterferon plus tenofov..:

Anastasiou, Olympia Aevdoxia ; Caruntu, Florin Alexandru ; Curescu, Manuela Gabriela...
Journal of Hepatology. 78 (2023) - p. S1137 , 2023

Link: https://doi.org/10.1016/..

2

Week 96 Efficacy and Safety Results of Tenofovir Alafenamid..:

Brunetto, Maurizia Rossana ; Lim, Young-Suk ; Gane, Edward...
Gastroenterology. 152 (2017) 5 - p. S1086 , 2017

Link: https://doi.org/10.1016/..

3

Comparative activity of carbapenem testing (the COMPACT stu..:

Turkish COMPACT Study Group ; Leblebicioglu, Hakan ; Cakir, Nedim...
BMC Infectious Diseases. 12 (2012) 1 - p. , 2012

Link: https://doi.org/10.1186/..

4

Stevens-Johnson syndrome caused by combined use of lamotrig..:

Uluğ, Mehmet ; Uluğ, Nuray ; Celen, Mustafa..
Open Medicine. 5 (2010) 6 - p. 733-736 , 2010

Link: https://doi.org/10.2478/..

5

Treatment initiation rates of patients with positive anti-h..:

Çelen, Mustafa K ; Ertürk Şengel, Buket ; Kaya, Şafak...
The Journal of Infection in Developing Countries. 18 (2024) 3 - p. 441-449 , 2024

Link: https://doi.org/10.3855/..

6

The Analysis of the Correlations between Quantitative HBsAG..:

Deveci, Özcan ; Mermutluoğlu, Çiğdem ; Cerrah, Serkan...
International Journal of Medical Science and Clinical Invention. 10 (2023) 11 - p. 6951-6955 , 2023

Link: https://doi.org/10.18535..

7

Five‐year follow‐up of 96 weeks peginterferon plus tenofovi..:

Anastasiou, Olympia E. ; Caruntu, Florin A. ; Curescu, Manuela G....
Liver International. 44 (2023) 1 - p. 139-147 , 2023

Link: https://doi.org/10.1111/..

8

Comparison of Immunological and Virological Recovery with R..:

Sarıgül Yıldırım, Figen ; Candevir, Aslıhan ; Akhan, Sıla...
International Journal of General Medicine. 16 (2023) - p. 1867-1877 , 2023

Link: https://doi.org/10.2147/..

9

Quality‐of‐life scores improve after 96 weeks of PEG‐IFNa‐2..:

Dinkelborg, Katja ; Kahlhöfer, Julia ; Dörge, Petra...
Liver International. 43 (2023) 8 - p. 1663-1676 , 2023

Link: https://doi.org/10.1111/..

10

P1- HIGH VIRAL SUPPRESSION AND IMPROVED SAFETY PROFILE OF T..:

Seto, Wai Kay ; Chang, Ting-Tsung ; Chowdhry, Abhijit...
Annals of Hepatology. 28 (2023) - p. 100905 , 2023

Link: https://doi.org/10.1016/..

11

Long-Term Treatment With Tenofovir Alafenamide for Chronic ..:

Chan, Henry L.Y. ; Buti, Maria ; Lim, Young-Suk...
American Journal of Gastroenterology. 119 (2023) 3 - p. 486-496 , 2023

Link: https://doi.org/10.14309..

12

Comparison of Tenofovir Alafenamide and Entecavir Therapy i..:

Akdemir Kalkan, Irem ; Karasahin, Omer ; Sarigul, Figen...
Hepatitis Monthly. 21 (2022) 10 - p. , 2022

Link: https://doi.org/10.5812/..

13

Evaluation of inflammatory and hematological parameters in ..:

Mermutluoğlu, Çiğdem ; Dursun, Recep ; Aktar, Fesih...
The Journal of Infection in Developing Countries. 16 (2022) 10 - p. 1564-1569 , 2022

Link: https://doi.org/10.3855/..

14

The Effects of the COVID-19 Pandemic on Clinical and Labora..:

Akgul, Fethiye ; Arslan, Yusuf ; Celik, Mehmet..
Hepatitis Monthly. 22 (2022) 1 - p. , 2022

Link: https://doi.org/10.5812/..

15

Efficacy and safety of an inactivated whole-virion SARS-CoV..:

Tanriover, Mine Durusu ; Doğanay, Hamdi Levent ; Akova, Murat...
The Lancet. 398 (2021) 10296 - p. 213-222 , 2021

Link: https://doi.org/10.1016/..